Delivery Order SPE2DB20D2104-SPE2DB24FS53Y
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $34,316.57 fixed-price delivery order is for the procurement of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,025.13, is a delivery order for the supply of 4563551117 UROXATRAL 10 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of February 6, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $35,120.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of UROXATRAL 10 MG TABLET 100S, with an ultimate completion date of October 13, 2023. The contract is a Firm Fixed Price agreement, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Uroxatral 10 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $8,974.85 and a completion date of February 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,254.34, is for the delivery of Uroxatral 10 mg tablets to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,169.94 Firm Fixed Price Delivery Order contract covers the supply of 4562815931 UROXATRAL 10 MG TABLET 100S, a pharmaceutical product, with a period of performance through November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,934.88 firm-fixed-price delivery order is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2023 and was awarded on December 1, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $107,084.18 Firm Fixed Price Delivery Order covers the supply of Uroxatral 10 mg tablets for military healthcare programs. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,361.73 fixed-price delivery order is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of UROXATRAL 10 MG TABLET 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $140,956.54 and is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS53YDelivery Order
This federal contract award, valued at $11,796.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of February 13, 2024 and is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 2/12/24 |